UNSPSC 51392302: Broxaterol

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51392302

Definition

This classification denotes a beta-adrenergic agonist with the molecular formula C9H15BrN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZE4IRB4DUC, chemically known as 3-bromo-alpha-(((1,1-dimethylethyl)amino)methyl)isoxazole-5-methanol but generally known as broxaterol, which bears US NIH Compound Identifier 71149. European Medicines Agency schedules Broxaterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05937MIG.

Read the full definition

The term BROXATEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, No. 6, 1984, List 24). BROXATEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule broxaterol under HS 29349990 and SITC 51579. As of Q4 2014, BROXATEROL remains the US FDA Preferred Term for this commodity. Broxaterol bears US NLM identifiers UMLS ID C0054156 and NCI Concept Code C74195. SMILES: BRC1NOC(C(O)CNC(C)(C)C)C1.

About UNSPSC 51392302

UNSPSC 51392302 Broxaterol is a Commodity code that captures pharmaceutical products state and local governments procure for public health and emergency-response programs. Based on recent solicitations, the code encompasses naloxone (opioid-reversal medication) and related drug-management systems that support community health initiatives and harm-reduction operations. State and local health departments, county health systems, and special-purpose public health agencies issue solicitations under this code, typically through competitive bidding processes that require vendors to meet federal compliance standards, insurance coverage thresholds, and workplace certification requirements such as E-Verify eligibility and drug-free workplace verification.

Recent activity shows procurement concentration in Florida and Texas. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the IFB response deadline was July 26, 2023, with electronic submission required through the county's e-Procurement Portal. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs and vendor capabilities for state pharmacy benefit contracting, signaling preliminary groundwork for larger procurement initiatives. Contracts under the code typically carry two-year initial terms with renewal options and fixed-fee or negotiated net-pricing structures; vendors must absorb shipping and delivery costs and maintain workers' compensation, commercial general liability, and professional liability insurance. Procurement may draw FEMA funding and carries corresponding federal compliance obligations including Clean Air Act and Federal Water Pollution Control Act adherence.

Quick answers

What is UNSPSC 51392302?

UNSPSC 51392302 is Broxaterol, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51392302?

UNSPSC 51392302 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51392302

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code